The impact of inflammatory markers on prognosis of stage II colon cancers depends on tumour sidedness.

Jui-Shen ChangHou-Hsuan ChengSheng-Chieh HuangHung-Hsin Lin Shih-Ching Chang Chun-Chi Lin

Published in: ANZ journal of surgery (2022)

The profiles and prognostic impact of inflammatory markers are significantly different between stage II RCC and LCC patients. Researchers should take sidedness into consideration when addressing survival analysis of inflammatory markers.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
renal cell carcinoma
patient reported outcomes
young adults